TickerHumSide-by-side comparison
Becton, Dickinson and vs Boston Scientific
As of Nov 11, 2026, P/E is 64.2x for Becton, Dickinson and vs 19.2x for Boston Scientific; P/S is 2.6x for Becton, Dickinson and vs 3.1x for Boston Scientific; revenue growth is 18.5% for Becton, Dickinson and vs 8.9% for Boston Scientific; operating margin is 10.7% for Becton, Dickinson and vs 18.7% for Boston Scientific.
What stands out
- Boston Scientific is cheaper on earnings: 19.2x P/E vs 64.2x for Becton, Dickinson and.
- Boston Scientific keeps more of each sale as operating profit: 18.7% margin vs 10.7% for Becton, Dickinson and.
- Becton, Dickinson and's shares did better over the past year: +40.7% vs -56.4% for Boston Scientific.
Key metrics
| Metric | BDX | BSX |
|---|---|---|
| Price | $212.46 | $45.45 |
| Market cap | $57.87B | $65.87B |
| P/E | 64.2x (#2) | 19.2x (#1) |
| P/S | 2.6x (#1) | 3.1x (#2) |
| Revenue growth | 18.5% (#1) | 8.9% (#2) |
| Operating margin | 10.7% (#2) | 18.7% (#1) |
| Net margin | 4.2% (#2) | 16.6% (#1) |
| Debt / equity | 0.55 (#2) | 0.43 (#1) |
| 1-year return | +40.7% (#1) | -56.4% (#2) |
| Research score | 52/100 (#1) | 50/100 (#2) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Becton, Dickinson and Company (BDX) — Medical Instruments & Supplies
- Boston Scientific Corporation (BSX) — Medical Devices